2013 COA Annual Meeting: An International Randomized Clinical Trial Evaluating Bst-Cargel, A Novel Scaffold For Cartilage Repair, Demonstrates Superiority Of Repair When Compared With Microfracture Alone Treatment

80 patients with an articular cartilage lesion, located on their femoral condyle, were randomized to undergo microfracture surgery with or without receiving BST-CarGel, to assess the efficacy and safety of BST-CarGel. 12 month results demonstrated that there was significantly greater improvement in quality and quantity of cartilage repair tissue in the BST-CarGel group, in comparison to the microfracture alone. In addition, there were no significant differences between the two groups in regard to safety.